3 ms·
> Generics manufacturers, incidentally, do just fine, and I can imagine a more sustainable model of pharmacological research where a generics builds up an R&D w
by tzs 12y ago
> Generics manufacturers, incidentally, do just fine, and I can imagine a more sustainable model of pharmacological research where a generics builds up an R&D war chest and periodically discharges it on new research.
Why would the generics manufacturers want to do that instead of treating that money as profits for the shareholders?
As long as they can keep their manufacturing facilities humming along at capacity cranking out the generics we already have for numerous chronic conditions, do they really care if new generics are being developed?
- dnautics 12y agoReally? http://www.equitymaster.com/detail.asp?date=09/04/1999&story=1&title=Cipla-in-high-gear-ups-RD-budget http://www.equitymaster.com/detail.asp?date=09/04/1999&story... For example.